Both in Pharmaceuticals
ANI Pharmaceuticals vs Ocular Therapeutix
Over the past year ANIP returned −23.1% and OCUL returned −36.8%; their daily moves had a correlation of 0.09.
ANIP −23.1% OCUL −36.8%Growth of $1, one year, split-adjusted
| Metric | ANIP | OCUL |
|---|---|---|
| Price | $71.71 | $7.29 |
| Market cap | $1.65B | $1.60B |
| Today | +0.76% | +8.48% |
| 1 month | −1.3% | −7.4% |
| 6 months | −8.0% | −20.8% |
| Year to date | −9.2% | −40.0% |
| 1 year | −22.8% | −36.9% |
| Revenue growth (YoY) | +25.9% | +0.1% |
| Gross margin | 62.4% | 85.1% |
| Net margin | 8.6% | −584.5% |
| P/E (TTM) | 16.5× | — |
| Price / sales | 1.7× | 30.8× |
| Net cash | -$234.7M | $525.8M |
| Dividend yield | — | — |
| Volatility (60d) | 29.5% | 75.9% |
| Short % of float | 18.1% | 15.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).